Target intelligence / Profile preview

ER membrane protein complex subunit 9 (EMC9)

Target
EMC9
Molecular classification
Other (Non-enzymatic, non-receptor protein), ER membrane protein complex subunit, Structural protein in a multi-protein membrane insertase complex
01

Overview

ER membrane protein complex subunit 9 (EMC9) is a protein component of the endoplasmic reticulum (ER) membrane protein complex (EMC), which is essential for the biogenesis and insertion of transmembrane domains of multi-pass and tail-anchored membrane proteins into the ER membrane[2][3][8][11]. EMC9 is a cytosolic cap subunit that forms a subcomplex with EMC2 and can be interchangeable with EMC8 in mammals[8][11]. The EMC as a whole acts as a membrane insertase, facilitating the topologically correct, energy-independent integration of nascent membrane proteins into the ER, indirectly impacting diverse cellular processes such as signal transduction and protein trafficking[2][3][11]. Dysfunction of EMT9 or the EMC complex can lead to a variety of developmental and disease states, including neurological defects, visual impairment, and retinoblastoma[2]. EMC9 is not generally considered a direct therapeutic target; rather, it is required for the assembly and proper function of the EMC insertase machinery[2][3][8][11].

Other names
FAM158AC14orf122CGI-112
02

Mechanism of action

Not applicable; no known drugs target EMC9 directly

03

Biological functions

Protein insertion into ER membrane (membrane protein biogenesis)Assembly and stability of the ER membrane protein complexFacilitates insertion of tail-anchored and multi-pass membrane proteins
04

Disease associations

Cancer (e.g., Retinoblastoma)Neurological disorders (Cerebellar atrophy, psychomotor retardation, visual impairment)
05

Safety considerations

None specific for EMC9. As a non-druggable structural protein, safety concerns relate to disruption of ER membrane protein complex integrity rather than direct drug targeting

Beyond the preview

Go deeper on ER membrane protein complex subunit 9 (EMC9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ER membrane protein complex subunit 9 (EMC9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call